Showing results (71-80 of 272) with videos related to

Sort By:
Pageof 28
Clinical Genitourinary Cancer|April 11, 2021
Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder CancerTrevor J Royce, Yuan Liu, Matthew I Milowsky, et al.
The Journal of Urology|October 28, 2025
Impact of renal mass biopsy on decision-making experience for clinical T1 renal massesKathryn H Gessner, Allison M Deal, Amir Feinberg, et al.
The Journal of Clinical Investigation|August 16, 2021
Entinostat induces antitumor immune responses through immune editing of tumor neoantigensAndrew S Truong, Mi Zhou, Bhavani Krishnan, et al.
Urologic Oncology|January 9, 2014
Highlights from the first symposium on upper tract urothelial carcinomaSurena F Matin, Shahrokh F Shariat, Matthew I Milowsky, et al.
Nature Communications|November 5, 2022
Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancerJeffrey S Damrauer, Wolfgang Beckabir, Jeff Klomp, et al.
Nature Communications|December 13, 2025
APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signalingMichael S Sturdivant, Andrew S Truong, Mi Zhou, et al.
The Journal of Urology|May 8, 2024
Decisional Conflict Among Patients Newly Diagnosed With Clinical T1 Renal Masses: A Prospective StudyAmir Feinberg, Kathryn H Gessner, Allison M Deal, et al.
Cancer Research Communications|August 8, 2024
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic FeaturesN Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi, et al.
Pageof 28